David R Rappange

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. ncbi Lifestyle intervention: from cost savings to value for money
    David R Rappange
    Department of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, Rotterdam, The Netherlands
    J Public Health (Oxf) 32:440-7. 2010
  2. ncbi Healthcare costs and obesity prevention: drug costs and other sector-specific consequences
    David R Rappange
    Erasmus University Medical Centre, Department of Health Policy and Management and Institute for Medical Technology Assessment, Rotterdam, The Netherlands
    Pharmacoeconomics 27:1031-44. 2009
  3. ncbi Back to the Consideration of Future Consequences Scale: time to reconsider?
    David R Rappange
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Medical Center, P O Box 1738, 3000DR, Rotterdam, The Netherlands
    J Soc Psychol 149:562-84. 2009
  4. ncbi The evaluation of lifestyle interventions in the Netherlands
    David R Rappange
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Health Econ Policy Law 7:243-61. 2012
  5. ncbi Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?
    David R Rappange
    Department of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, The Netherlands
    Pharmacoeconomics 26:815-30. 2008

Detail Information

Publications5

  1. ncbi Lifestyle intervention: from cost savings to value for money
    David R Rappange
    Department of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, Rotterdam, The Netherlands
    J Public Health (Oxf) 32:440-7. 2010
    ....
  2. ncbi Healthcare costs and obesity prevention: drug costs and other sector-specific consequences
    David R Rappange
    Erasmus University Medical Centre, Department of Health Policy and Management and Institute for Medical Technology Assessment, Rotterdam, The Netherlands
    Pharmacoeconomics 27:1031-44. 2009
    ..Sector-specific financial consequences of preventing obesity are less well documented, for pharmaceutical spending as well as for other healthcare segments...
  3. ncbi Back to the Consideration of Future Consequences Scale: time to reconsider?
    David R Rappange
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Medical Center, P O Box 1738, 3000DR, Rotterdam, The Netherlands
    J Soc Psychol 149:562-84. 2009
    ..From the findings, the authors raise questions regarding the construct validity of the CFC Scale, the interpretation of its results, and the usefulness of the CFC scale in its current form in applied research...
  4. ncbi The evaluation of lifestyle interventions in the Netherlands
    David R Rappange
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Health Econ Policy Law 7:243-61. 2012
    ..Improvements of the decision-making framework in the Netherlands are required to guarantee sound evaluations of lifestyle interventions aimed at improving health...
  5. ncbi Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?
    David R Rappange
    Department of Health Policy and Management and Institute for Medical Technology Assessment, Erasmus University Medical Center, Rotterdam, The Netherlands
    Pharmacoeconomics 26:815-30. 2008
    ..We therefore conclude that the inclusion of unrelated medical costs should become the new standard...